News

Abraxane is a solvent-free chemotherapy treatment option for metastatic breast cancer which was developed using Abraxis BioScience’s proprietary nab technology platform. Abraxis BioScience said that it has granted

Abbott said that Simcor is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone. Simcor is approved

As per the terms of the extended agreement, Regeneron Pharma is expected to receive $165m upfront and another $130m in June 2018 from Astellas, unless it terminates the

A5 Labs said that its patent application describes its new method for producing therapeutic proteins as well as specifically providing details of the production of its product VI-1718.

With the approval, Quest Diagnostics offers the test to physicians in New York as well as in all other US states. Quest Diagnostics said that the physicians can

In the trial, Teva has evaluated the efficacy and safety of Beclomethasone dipropionate (BDP) HFA nasal aerosol in the treatment ofSAR. Teva’s Phase III SAR trial was a

Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc

Nektar Therapeutics has posted a net loss of $517m for the second quarter 2010, or $0.01 loss per diluted share, compared to net loss of $32.1m, or $0.35

PDL BioPharma has posted a net income of $50.1m for the second quarter 2010, or $0.30 per diluted share, compared to net income of $77.2m, or $0.47 per